NCT06362122
- Conditions
- Nasal Polyps, Nose Diseases, Otorhinolaryngologic Diseases, +4 more
- Locations
-
- Chu Poitiers Poitiers, France
Clinical trial condition
Nasal Polyps
Explore clinical trials studying Nasal Polyps. Study availability and eligibility vary by location and protocol.
69 public trials
11 recruiting studies
Nasal Polyps trial results
Not yet recruiting
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07782970
- Conditions
- Nasal Polyps, Nose Diseases, Otorhinolaryngologic Diseases, +5 more
- Locations
-
Not specified
Active, not recruiting
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
NCT05575037
- Conditions
- Aspirin-Sensitive Asthma With Nasal Polyps, Aspirin-exacerbated Respiratory Disease, Asthma, +16 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Active, not recruiting
Pilot Study of The EPIC Trial
NCT02533206
- Conditions
- Infections, Nasal Polyps, Nose Diseases, +8 more
- Locations
-
- Royal Victoria Hospital Barrie, Ontario, Canada
- St Joseph's Health Care London, Ontario, Canada
- The Ottawa Hospital Ottawa, Ontario, Canada
- Algoma District Medical Group Sault Ste. Marie, Ontario, Canada
Active, not recruiting
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT06639295
- Conditions
- Infections, Nasal Polyps, Nose Diseases, +8 more
- Locations
-
- Site 01 Beijing, Beijing Municipality, China
Active, not recruiting
Dupixent Study for Alternate Administration
NCT06750471
- Conditions
- Chronic Disease, Disease Attributes, Infections, +11 more
- Locations
-
- Madigan Army Medical Center Tacoma, Washington, United States
NCT04607005
- Conditions
- Nasal Polyps, Nose Diseases, Otorhinolaryngologic Diseases, +4 more
- Locations
-
- GSK Investigational Site Chiba, Japan
NCT03085797
- Conditions
- Nasal Polyps, Nose Diseases, Otorhinolaryngologic Diseases, +4 more
- Locations
-
Not specified
NCT05274750
- Conditions
- Nasal Polyps, Nose Diseases, Otorhinolaryngologic Diseases, +4 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Buena Park, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Diego, California, United States
NCT05672030
- Conditions
- Aspirin-exacerbated Respiratory Disease, Nasal Polyps, Nose Diseases, +5 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States